Statistics

Total Visits

Views
Pazopanib in metastatic renal carcinoma (mRC): Experience of 31 centers in Spain in first, second, third, or subsequent lines in daily clinical practice13

Select a period of time:

Number of views in the range

Views
Pazopanib in metastatic renal carcinoma (mRC): Experience of 31 centers in Spain in first, second, third, or subsequent lines in daily clinical practice10

Views

Views
May 20241
June 20243
July 20244
August 20241
September 20241
October 20240
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
United Kingdom2
 

Top cities views

Views
Chicago1